Cytochalasin B, an alkaloid that inhibits a wide variety of cellular movements, interacts with actomyosin, the contractile protein complex of striated muscle. This interaction causes a decrease in viscosity of the actomyosin complex and an inhibition of acto-heavy meromyosin ATPase activity of at least 60%. Cytochalasin B does not affect the viscosity of myosin nor the ATPase activity of heavy meromyosin, suggesting that the drug might interact directly with the actin moiety of the actomyosin complex. Indeed, as judged by viscometry, there is a strong interaction of cytochalasin B with actin, at nearly stoichiometric concentrations. Myosin appears to compete with cytochalasin for binding to actin. (1), including blood platelets (2, 3), leucocytes (4), mammalian brain (5), sarcoma cells (6), seaurchin eggs (7), Acanthamoeba castellanii (8), plasmodia of the acellular slime mold, Physarum polycephalum (9-11), amoebae of the cellular slime mold, Dictyostelium discoideum (12), and most recently in epithelial cells of the chicken intestine (13). The similarity of these actin-like proteins with muscle actin is emphasized by the observations (11-16) that they interact with muscle heavy meromyosin (HMM) to give "arrowheads" similar to those originally observed by Huxley with muscle acto-HMM (17).
, including blood platelets (2, 3) , leucocytes (4), mammalian brain (5) , sarcoma cells (6) , seaurchin eggs (7) , Acanthamoeba castellanii (8) , plasmodia of the acellular slime mold, Physarum polycephalum (9) (10) (11) , amoebae of the cellular slime mold, Dictyostelium discoideum (12) , and most recently in epithelial cells of the chicken intestine (13) . The similarity of these actin-like proteins with muscle actin is emphasized by the observations (11) (12) (13) (14) (15) (16) ) that they interact with muscle heavy meromyosin (HMM) to give "arrowheads" similar to those originally observed by Huxley with muscle acto-HMM (17) .
Another indication that the molecular basis of many forms of movement may be related comes from studies using the drug cytochalasin B. This alkaloid, a metabolite of the fungus Helminthosporium dematioideum (18) , inhibits a wide variety of cellular movements (18) (19) (20) . To our knowledge, nothing is known about the mode of action of cytochalasin B at the molecular level.
Since actomyosin-like proteins and cytochalasin B have both been implicated in cellular movement in several orgaAbbreviations: Actin, filamentous actin or F-actin (the monomer is specified as G-actin); CB-actin, actin saturated with cytochalasin B; Me2SO, dimethyl sulfoxide; HMM, heavy meromyosin (a proteolytic fragment of myosin retaining ATPase activity and the ability to interact with actin). 442 nisms, we have begun to investigate whether cytochalasin B inhibits movement by interacting with actomyosin-like proteins. We report here that cytochalasin B interacts with purified muscle actin and that it appears to compete with myosin for binding to the actin. (22) . Myosin was prepared from rabbit striated-muscle, as described by Tonomura et al. (23) , and HMM was obtained by cleavage of myosin with trypsin, followed by precipitation of light meromyosin and of the remaining myosin at low ionic strength (24) .
MATERIALS AND METHODS

Reagents
Assay of Adenosine Triphosphatase Activity. The ATPase activity of acto-HMM (in the presence of 0.2 mM Ca2+) was determined as described (22) , except for minor modifications described in the legends.
Viscometry. The (3.1 ml/mg) far above the viscosities for myosin* or actin alone (about 0.2 ml/mg and 0.8 ml/mg, respectively). This highly viscous actomyosin complex was rapidly dissociated by the addition of ATP, but the actin and myosin reassociated within 30 min (as the ATP was hydrolyzed). These viscosity changes are well-known characteristics of muscle actomyosin (26) . Addition of cytochalasin at 117 mini caused a large and rapid decrease in the viscosity of the actomyosin complex.
The results of the second experiment, in which the actomyosin complex was formed after the addition of cytochalasin, were as follows ( . The Me2SO did not have a significant effect on the acto-HMM ATPase activity. Some variability was observed in the assays with Me2SO and cytochalasin. Thus, the above points represent averages of up to five determinations (which differed from one another by as much as 25% inhibition) at a given cytochalasin concentration, where each determination-was an average of at least duplicate assays. Maximum inhibition was observed at about pH 7.4, with final concentrations of Tris and maleate of 12.5 mM each; otherwise, ATPase activity was determined as described (22) . muscle contraction. We used HMM for this study since HMM, unlike myosin, is soluble under the conditions of our ATPase assay. We found that the actin-activation of HMM ATPase activity was inhibited up to about 60% by the addition of cytochalasin B (Fig. 2) . A precipitate was apparent in the ATPase reaction mixtures containing 0.42 mM cytochalasin B, indicating that the cytochalasin was not completely soluble at this concentration.
Cytochalasin B does not appear to interact with myosin
The above experiments demonstrate that cytochalasin interacts with actomyosin. Does cytochalasin interact with myosin, with actin, or with both? It was already apparent that the viscosity of myosin alone was not affected by the drug (see Fig. 1 ). We also found that the ATPase activity of HMM alone (HMM is equivalent to myosin, in that its ATPase activity is activated by actin) was not significantly inhibited by cytochalasint. This finding is consistent with our observation that the time required for myosin to hydrolyze ATP, as judged by viscosity measurements, was not affected t Three independent determinations assayed as described (22) by cytochalasin (see Fig. 1 ). Thus, we have no evidence indicating an interaction of cytochalasin with myosin; therefore, we examined its effect on actin alone.
Cytochalasin B interacts with actin
Cytochalasin B Causes a Decrease in the Viscosity of Actin. It is well known that G-actin polymerizes in the presence of 0.1 M KCl to a filamentous form, F-actin. This polymerization, in the absence of cytochalasin, resulted in an increase in viscosity, to a value of about 0.8 ml/mg (Fig. 3, open circles) . Polymerization of G-actin in 0.1 M KCl occurred in the presence of cytochalasin B, but the viscosity of the resultant polymerized actin (which we have termed CB-actin) was only 0.5 ml/mg (Fig. 3, filled circles) . Addition of cytochalasin B to formerly polymerized actin rapidly transformed the Factin to the CB-actin form (Fig. 3, half-open circles) . It appears, therefore, that CB-actin can be formed by polymerization of G-actin in the presence of cytochalasin or by addition of cytochalasin directly to F-actin.
The reduced viscosity of F-actin increases with actin concentration, since the interaction of actin filaments with one another becomes'greater at higher concentrations of actin. To determine whether the intrinsic viscosity (the reduced viscosity extrapolated to zero protein concentration) of Factin is affected by cytochalasin B, the reduced viscosity at and on the viscosity of F-actin. G-,actin (2.9 ml, 1.1 mg/ml, t0red = 0.o0, ml/mg) in Buffer A (see Table 1 ) was mixed with 50,ql of Me2SO (0,CO) or with 50 ,ul of a 10 mg/ml solution of cytochalasin B (-). Me2SO Binding to Actin. One experiment that suggests competitive binding of myosin and cytochalasin is shown in Fig. 5 . Addition of F-actin to myosin in a 1:2 molar ratio increased the viscosity of the solution to 0.42 ml/mg. Addition of CBactin to myosin also increased the viscosity of the solution, but only to 0.33 ml/mg. The important observation is that addition of cytochalasin to the preformed actomyosin complex resulted in a very slow decrease in viscosity toward 0.33 ml/mg. This slow decrease in viscosity is in contrast to the very rapid effect of cytochalasin on the viscosity of Factin (see Fig. 3 ), and on that of actomyosin formed with an excess of actin (see Fig. 1 ). Thus, myosin appears to interfere with the interaction of cytochalasin and actin.
A further observation that is consistent with competition between myosin and cytochalasin for binding to actin is that the concentration of cytochalasin needed for 60% inhibition of acto-HMM ATPase activity (about 0.25 mM cytochalasin, see Fig. 2 ) is nearly ten times that required for 60% of the maximal decrease in intrinsic viscosity of actin alone (about 0.03 mM cytochalasin, see Fig. 4 ).
Yet another indication that myosin and cytochalasin compete for binding to actin is the observation that myosin appears to displace cytochalasin from CB-actin, as suggested by the following viscosity experiment ( Table 1) . Addition of myosin to undialyzed CB-actin (final concentration of cytochalasin was 0.057 mM) increased the viscosity of the solution to 1.74 ml/mg. On the other hand, addition of myosin to 0. (1972) What is the alteration in F-actin structure upon the addition of cytochalasin B? The observed decrease in viscosity could be a result of a change in the axial ratio of the F-actin filaments, either by partial depolymerization or by an increase in width of the filaments, or it could be a result of a decreased rigidity of the actin "rod".
